Next Biomedical Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Public

  • Employees
  • 77

Employees

  • Stock Symbol
  • 389650

Stock Symbol

  • Share Price
  • $19.71
  • (As of Friday Closing)

Next Biomedical General Information

Description

Nextbiomedical Co Ltd is an bio-solution company. The company develops and commercializes therapeutic agents for treating diseases based on polymer and drug delivery system technology. The company has developed products that include endoscopic hemostatic agents, vascular embolic microspheres, and others.

Contact Information

Website
www.nextbiomedical.co.kr
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 6, Venture-ro
  • 100beon-gil
  • Incheon, Yeonsu 22013
  • South Korea
+82
Primary Industry
Other Devices and Supplies
Other Industries
Drug Delivery
Surgical Devices
Stock Exchange
KRX
Vertical(s)
TMT, Life Sciences
Corporate Office
  • 6, Venture-ro
  • 100beon-gil
  • Incheon, Yeonsu 22013
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Next Biomedical Stock Performance

As of 13-Nov-2026, Next Biomedical’s stock price is $19.71. Its current market cap is $163M with 8.28M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$19.71 $20.68 $18.77 - $68.84 $163M 8.28M 26.1K $0.02

Next Biomedical Financials Summary

As of 30-Jun-2026, Next Biomedical has a trailing 12-month revenue of $12.3M.

In Thousands,
USD 		TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 205,120 491,979 214,469
Revenue 12,258 11,578 6,994 3,734
EBITDA 33 (247) 2,373 (5,395)
Net Income 160 (219) 2,096 (5,753)
Total Assets 41,204 41,156 39,949 23,003
Total Debt 4,506 5,355 7,434 8,939
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Next Biomedical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Next Biomedical‘s full profile, request access.

Request a free trial

Next Biomedical Patents

  • 57

    Total Documents Applications and Grants

  • Total Patents Families

  • 35

    Granted

  • 8

    Pending

  • Expiring in next 12 mo

Next Biomedical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023222956-A1 Dispenser device for spraying powder Active 03-Mar-2023
AU-2023222956-B2 Dispenser device for spraying powder Active 03-Mar-2023
AU-2025223902-A1 Dispenser device for spraying powder Pending 03-Mar-2023
EP-4424346-A1 Dispenser device for spraying powder Active 03-Mar-2023
EP-4424346-B1 Dispenser device for spraying powder Active 03-Mar-2023 B05B7/1463
To view Next Biomedical’s complete patent history, request access »

Next Biomedical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Next Biomedical ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Next Biomedical’s complete esg history, request access »

Next Biomedical FAQs

  • When was Next Biomedical founded?

    Next Biomedical was founded in 2014.

  • Where is Next Biomedical headquartered?

    Next Biomedical is headquartered in Incheon, South Korea.

  • What is the size of Next Biomedical?

    Next Biomedical has 77 total employees.

  • What industry is Next Biomedical in?

    Next Biomedical’s primary industry is Other Devices and Supplies.

  • Is Next Biomedical a private or public company?

    Next Biomedical is a Public company.

  • What is Next Biomedical’s stock symbol?

    The ticker symbol for Next Biomedical is 389650.

  • What is the current stock price of Next Biomedical?

    As of 13-Nov-2026 the stock price of Next Biomedical is $19.71.

  • What is the current market cap of Next Biomedical?

    The current market capitalization of Next Biomedical is $163M.

  • What is Next Biomedical’s current revenue?

    The trailing twelve month revenue for Next Biomedical is $12.3M.

  • What is Next Biomedical’s annual earnings per share (EPS)?

    Next Biomedical’s EPS for 12 months was $0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process